This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Insiders are Scooping Up

From a technical perspective, LYV is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strongly for the last two months, with shares moving higher from $8.39 to its recent high of $10.12 a share. During that uptrend, shares of LYV have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of LYV within range of triggering a near-term breakout trade.

If you're in the bull camp on LYV, then I would look for long-biased trades if this stock manages to break out above some near-term overhead resistance at $10.12 a share with high volume. Look for a sustained move or close above $10.12 a share with volume that registers near or above its three-month average action of 871,951 shares. If that breakout triggers soon, then LYV will set up to re-test or possibly take out its next major overhead resistance levels at $10.99 to $11.50 a share.

Novabay Pharmaceutical

One final name to consider with some decent insider buying is Novabay Pharmaceutical (NBY - Get Report). This is a clinical stage pharmaceutical company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments. Insiders are buying this stock into modest weakness, since shares are off by 10% in the last three months.

Novabay Pharmaceutical has a market cap of $35 million and an enterprise value of $22 million. This stock trades at a fair valuation, with a price-to-sales of 4.86 and a price-to-book of 4.60. Its estimated growth rate for this year is -35%, and for next year it's pegged at 11.1%. This is a cash-rich company, since the total cash position on its balance sheet is $11.88 million and its total debt is zero.

The president and beneficial owner just bought 120,000 shares, or about $144,000 worth of stock, at $1.20 per share.

From a technical perspective, NBY is currently trending below both its 50-day and 200-day moving averages, which is bearish. This stock has been downtrending badly for the last month, with shares dropping from $1.76 to its recent low of $1.05 a share. During that downtrend, shares of NBY have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of NBY have started to rebound off that $1.05 low and move within range of triggering a near-term breakout trade.
5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
GEVA $238.60 1.19%
END $0.01 -1.33%
LYV $25.41 -0.78%
NBY $0.32 -5.88%
OMER $11.67 -2.10%


Chart of I:DJI
DOW 17,081.89 -49.97 -0.29%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,796.6090 -42.0340 -0.87%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs